To verify whether the identified population EpCAM+ CD4+ T cells increased in patients with benign polyps, we examine a cohort of patients with colonic polyps (CP) and determine their T cell subset landscape using the same mass cytometry staining panel above (Supplementary Table 2). The gene discussed is CD4; the disease is colon inflammatory polyp.